The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Activation of the hepatic LDL receptor promoter by thyroid hormone.
Abstract
The question of whether mature sterol regulatory element binding protein-2 (SREBP-2) mediates transcriptional activation of the hepatic low density lipoprotein (LDL) receptor by thyroid hormone was investigated. Western blotting analysis and electrophoretic mobility shift assays demonstrated that mature nuclear SREBP-2 protein could be detected in liver nuclear extracts prepared from normal animals but not in extracts prepared from rats rendered hypothyroid either by hypophysectomy (Hx) or thyroidectomy (Tx). Treatment of Hx rats with T3 restored LDL receptor mRNA levels in about 1 h and caused a 6-fold increase 2.5 h after T3 administration. However, no detectable mature SREBP-2 was seen in this time period despite a substantial reduction in serum cholesterol levels caused by the T3 treatment. Deletion of the SRE region from the LDL receptor promoter did not decrease the T3 response. Thus, the possibility that T3 may be mediating LDL receptor induction directly via a thyroid response element (TRE) was investigated. Reporter gene analysis and electrophoretic mobility shift assays demonstrated that the rat LDL receptor promoter contains two functional TREs (US-TRE and 2H-TRE). Either one of these elements could support T3 induction. However, the stronger of these elements is US-TRE at-612 which binds TRbeta1 more tightly and when mutated results in a diminished T3 response. These results indicate that the rapid induction of the hepatic LDL receptor by thyroid hormone is likely…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Under low intracellular sterol levels, LDLR gene expression is primarily and directly activated by SREBPs and secondarily by thyroid hormone.
“Under low intracellular sterol levels, LDLR gene expression is primarily and directly activated by sterol response element-binding proteins (SREBPs) [18] and secondarily by thyroid hormone [19].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [19]
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Flagged first, then by citations
Research works printed but not linked: 52
- Walton, 1965, The significance of alterations in serum lipids in thyroid dysfunction, I. The relation between serum lipoproteins, carotenoids and vitamin A in hypothyroidism and thyrotoxicosis, Clin. Sci., 29, 199
- Illingworth, 1981, Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia, Clin. Endocrinol., 14, 145, 10.1111/j.1365-2265.1981.tb00609.x · DOI
- Ness, 1990, Effect of thyroid hormone on hepatic cholesterol 7α hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthase and apolipoprotein A-I mRNA levels in hypophysectomized rats, Biochem. Biophys. Res. Commun., 172, 1150, 10.1016/0006-291X(90)91568-D · DOI
- Cappola, 2003, Hypothyroidism and atherosclerosis, J. Clin. Endocrinol. Metab., 88, 2438, 10.1210/jc.2003-030398 · DOI
- Hansson, 1983, Experimental hyperthyroidism in man. Effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase, Horm. Metab. Res., 15, 449, 10.1055/s-2007-1018751 · DOI
- Ness, 1991, Thyroid hormone: basis for its hypocholesterolemic effect, J. Fla. Med. Assoc., 78, 383
- Underwood, 1986, A thyromimetics that decreases plasma cholesterol levels without increasing cardiac activity, Nature, 324, 425, 10.1038/324425a0 · DOI
- Stephan, 1992, Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid, Biochem. Pharmacol., 43, 1969, 10.1016/0006-2952(92)90640-5 · DOI
- Engelken, 1981, The effects of altered thyroid status on lipid metabolism in the genetic hyperlipemic Zucker rat, Atherosclerosis, 38, 177, 10.1016/0021-9150(81)90114-3 · DOI
- Aviram, 1982, Lipid and lipoprotein patterns in thyroid dysfunction and the effect of therapy, Clin. Biochem., 15, 62, 10.1016/S0009-9120(82)90529-X · DOI
- Thompson, 1981, Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo, Proc. Natl. Acad. Sci. U. S. A., 78, 2591, 10.1073/pnas.78.4.2591 · DOI
- Leeson, 1989, Selective thyromimetics. Cardiac-sparing thyroid hormone analogues containing 3′-arylmethyl substituents, J. Med. Chem., 32, 320, 10.1021/jm00122a009 · DOI
- Walton, 1965, The significance of alterations in serum lipids in thyroid dysfunction, II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis, Clin. Sci., 29, 217
- Morkin, 2004, Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects, J. Mol. Cell. Cardiol., 37, 1137
- Ness, 1998, Effects of l-triiodothyronine and the thyromimetric L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression, Biochem. Pharmacol., 56, 121, 10.1016/S0006-2952(98)00119-1 · DOI
- Salter, 1991, Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver, Biochem. J., 276, 825, 10.1042/bj2760825 · DOI
- Ness, 1994, Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats, Arch. Biochem. Biophys., 315, 199, 10.1006/abbi.1994.1490 · DOI
- Staels, 1990, Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats, Endocrinology, 127, 1144, 10.1210/endo-127-3-1144 · DOI
- Hudig, 1997, Triiodothyronine prevents the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor gene, J. Endocrinol., 152, 413, 10.1677/joe.0.1520413 · DOI
- Ness, 1995, Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7α hydroxylase by thyroid hormone, Arch. Biochem. Biophys., 323, 404, 10.1006/abbi.1995.0061 · DOI
- Dueland, 1993, Effect of dietary cholesterol and taurocholate on cholesterol 7α-hydroxylase and hepatic LDL receptors in inbred mice, J. Lipid Res., 34, 923, 10.1016/S0022-2275(20)39679-6 · DOI
- Mistry, 1981, Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells, J. Clin. Invest., 67, 493, 10.1172/JCI110058 · DOI
- Applebaum-Bowden, 1984, Down-regulation of the low-density lipoprotein receptor by dietary cholesterol, Am. J. Clin. Nutr., 39, 360, 10.1093/ajcn/39.3.360 · DOI · Paper page
- Hennessy, 1992, Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoproteins A-I, B, and E and LDL receptor mRNA levels in cebus monkeys, J. Lipid Res., 33, 351, 10.1016/S0022-2275(20)41525-1 · DOI
- Kovanen, 1981, Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits, Proc. Natl. Acad. Sci. U. S. A., 78, 1396, 10.1073/pnas.78.3.1396 · DOI
- Rudling, 1993, Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression, Proc. Natl. Acad. Sci. U. S. A., 90, 8851, 10.1073/pnas.90.19.8851 · DOI
- Südhof, 1987, 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter, Cell, 48, 1061, 10.1016/0092-8674(87)90713-6 · DOI · Paper page
- Bishop, 1992, Structure of the hamster low density lipoprotein receptor gene, J. Lipid Res., 33, 549, 10.1016/S0022-2275(20)41620-7 · DOI
- Hoffer, 1993, The mouse low density lipoprotein receptor gene: cDNA sequence and exon–intron structure, Biochem. Biophys. Res. Commun., 191, 880, 10.1006/bbrc.1993.1299 · DOI
- Mehta, 1991, The low density lipoprotein receptor in Xenopus laevis, II. Feedback repression mediated by conserved sterol regulatory element, J. Biol. Chem., 266, 10415, 10.1016/S0021-9258(18)99241-0 · DOI
- Osborne, 1995, Transcriptional control mechanisms in the regulation of cholesterol balance, Crit. Rev. Euk. Gene Exp., 5, 317, 10.1615/CritRevEukarGeneExpr.v5.i3-4.50 · DOI
- Magana, 1996, Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter, J. Biol. Chem., 271, 32689, 10.1074/jbc.271.51.32689 · DOI
- Ericsson, 1996, Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene, Proc. Natl. Acad. Sci. U. S. A., 93, 945, 10.1073/pnas.93.2.945 · DOI
- Sato, 1996, Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2, J. Biol. Chem., 271, 26461, 10.1074/jbc.271.43.26461 · DOI
- Hua, 1993, SREBP-2, a second basic-helix–loop–helix–leucine zipper protein that stimulates transcription by binding to a sterol regulatory element, Proc. Natl. Acad. Sci. U. S. A., 90, 11603, 10.1073/pnas.90.24.11603 · DOI · Paper page
- Yokoyama, 1993, SREBP-1, a basic helix–loop–helix–leucine zipper protein that controls transcription of the low density lipoprotein receptor gene, Cell, 75, 187, 10.1016/S0092-8674(05)80095-9 · DOI
- Briggs, 1993, Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter, I. Identification of the protein and delineation of its target nucleotide sequence, J. Biol. Chem., 268, 14490, 10.1016/S0021-9258(19)85265-1 · DOI · Paper page
- Wang, 1994, SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell, 77, 53, 10.1016/0092-8674(94)90234-8 · DOI
- Sato, 1994, Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element binding protein-1 (SREBP-1), J. Biol. Chem., 269, 17267, 10.1016/S0021-9258(17)32550-4 · DOI
- Shimano, 2001, Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes, Prog. Lipid Res., 40, 439, 10.1016/S0163-7827(01)00010-8 · DOI
- Hua, 1995, Hairpin orientation of sterol regulatory element binding protein-2 in cell membranes as determined by protease protection, J. Biol. Chem., 270, 29422, 10.1074/jbc.270.49.29422 · DOI
- Shin, 2003, Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2), J. Biol. Chem., 278, 34114, 10.1074/jbc.M305417200 · DOI
- Yu, 1995, Enhanced DNA-binding activity of Stat3-related protein in cells transformed by the Src oncoprotein, Science, 269, 81, 10.1126/science.7541555 · DOI · Paper page
- Lopez, 2006, Characterization of the rat LDL receptor 5′-flanking region, Biochim. Biophys. Acta, 1761, 492, 10.1016/j.bbalip.2006.03.012 · DOI
- Petty, 1990, Identification of a thyroid hormone response element in the malic enzyme gene, J. Biol. Chem., 265, 7395, 10.1016/S0021-9258(19)39126-4 · DOI
- Samuels, 1979, Depletion of l-3,5,3′-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone, Endocrinology, 105, 80, 10.1210/endo-105-1-80 · DOI
- Lopez, 2003, Peroxisome proliferator-activated receptor α induces rat sterol carrier protein X promoter activity through two peroxisome proliferator-response elements, Mol. Cell. Endocrinol., 205, 169, 10.1016/S0303-7207(02)00300-3 · DOI
- Lopez, 1999, Steroidogenic factor-1 mediates cyclic 3′,5′-adenosine monophosphate regulation of the high density lipoprotein receptor, Endocrinology, 140, 3034, 10.1210/endo.140.7.6846 · DOI
- Bakker, 1998, Effects of triiodothyronine and amiodarone on the human LDL receptor gene, Biochem. Biophys. Res. Commun., 249, 517, 10.1006/bbrc.1998.9174 · DOI
- Zandieh Doulabi, 2002, TRb1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation, Endocrinology, 143, 979, 10.1210/endo.143.3.8706 · DOI
- Flamant, 2003, Thyroid hormone receptors: lessons from knockout and knock-in mutant mice, Trends Endocrinol. Metab., 14, 85, 10.1016/S1043-2760(02)00043-7 · DOI · Paper page
- Murray, 1988, Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors, J. Biol. Chem., 263, 12770, 10.1016/S0021-9258(18)37820-7 · DOI
Cited by
Sorted by citations
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Mechanisms and regulation of cholesterol homeostasis
Luo, J., Yang, H., & Song, B.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0190-7 · Cited by 1,980
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation
Liu, Y.-Y., & Brent, G. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.004 · Cited by 218
Thyroid hormone signaling and the liver
Ritter, M. J., Amano, I., Hollenberg, A. N., et al. (2020) · Hepatology · doi:10.1002/hep.31296 · Cited by 188
Meier, S., Bell, M., Lyons, D. N., Rodriguez-Rivera, J., Ingram, A., Fontaine, S. N., Mechas, E., Chen, J., Wolozin, B., LeVine, H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3029-15.2016 · Cited by 190
Self-citationAbisambra, J. F., Fiorelli, T., Padmanabhan, J., Neame, P., Wefes, I., & Potter, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008556 · Cited by 42
Self-citationPlasma proteome and metabolome characterization of an experimental human thyrotoxicosis model
Pietzner, M., Engelmann, B., Kacprowski, T., Golchert, J., Dirk, A.-L., Hammer, E., Iwen, K. A., Nauck, M., Wallaschofski, H., Führer, D., et al. (2017) · BMC Medicine · doi:10.1186/s12916-016-0770-8 · Cited by 40
Metadata
- Authors
- Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 1771
- Issue
- 9
- Pages
- 1216-1225
- ISSN
- 1388-1981
- Cited by
- 109
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review